Delivery Order SPE2DB24D2208-SPE2DB25FHHTX
- Not listed
- The Defense Logistics Agency awarded a $5,298.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 gram units) on July 22, 2025, with completion expected by July 23, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The IDC serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Advair HFA 230/21 microgram inhalers in 12-gram units, with a contract ceiling value of $1,608.05. This firm fixed-price delivery order, which is due for completion by August 29, 2025, represents a non-competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The pharmaceutical product will...
- The Defense Logistics Agency awarded a $19,014.36 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,956.40 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Advair HFA 230-21 micrograms inhalers (12-gram units). This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a $2,618.19 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhaler (12 grams) on August 12, 2025, with completion targeted for August 13, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,468.83 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12 grams) with a completion date of September 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime...
- The Defense Logistics Agency awarded a $3,313.05 delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 gm) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a $2,965.10 delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed openly among qualified vendors. This delivery...
- The Defense Logistics Agency awarded a $6,460.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Advair HFA 115-21 mcg inhaler 12gm units, with an ultimate completion date of July 21, 2025. This delivery order represents a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- SPE2DB24D2208Indefinite Delivery Contract
- SPE2DB24D2208-SPE2DB25FHHTXDelivery Order
The Defense Logistics Agency awarded a $2,646.36 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm), with an ultimate completion date of June 13, 2025. This competitive award—utilizing firm fixed pricing with no set-aside designation—represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. AmerisourceBergen's DLA IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company's consistent receipt of competitive delivery orders across multiple therapeutic domains—from specialty medications to brand-name and generic drugs—demonstrates its capability to meet federal procurement requirements. This particular delivery order for the Advair respiratory medication aligns with AmerisourceBergen's established portfolio of pharmaceutical products supplied to federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/12/25 |